Document Detail


Ensuring drug safety: lessons from the thiazolidinediones.
MedLine Citation:
PMID:  17905143     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Authors:
-
Related Documents :
12394613 - Therapeutic drug monitoring of immunosuppressive drugs in kidney transplantation.
21371543 - Silica-lipid hybrid microcapsules: influence of lipid and emulsifier type on in vitro p...
19118133 - Vascular perfused segments of human intestine as a tool for drug absorption.
Publication Detail:
Type:  Comment; Editorial    
Journal Detail:
Title:  Lancet     Volume:  370     ISSN:  1474-547X     ISO Abbreviation:  Lancet     Publication Date:  2007 Sep 
Date Detail:
Created Date:  2007-10-01     Completed Date:  2007-10-09     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  2985213R     Medline TA:  Lancet     Country:  England    
Other Details:
Languages:  eng     Pagination:  1101     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Drug Toxicity
Humans
Hyperglycemia / drug therapy
Hypoglycemic Agents / adverse effects*,  therapeutic use
Myocardial Infarction / chemically induced*
Thiazolidinediones / adverse effects*,  therapeutic use
Chemical
Reg. No./Substance:
0/Hypoglycemic Agents; 0/Thiazolidinediones; 122320-73-4/rosiglitazone
Comments/Corrections
Comment On:
Lancet. 2007 Sep 29;370(9593):1129-36   [PMID:  17905165 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Foam film permeability: theory and experiment.
Next Document:  Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes g...